Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessment of avidity related to IgG subclasses in SARS-CoV-2 Brazilian infected patients
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-09-03
DOI
10.1038/s41598-021-95045-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Detection technologies and recent developments in the diagnosis of COVID-19 infection
- (2021) Praveen Rai et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- The potential significance of high avidity IgG for protective immunity towards SARS-CoV-2
- (2021) Georg Bauer INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals
- (2021) Tatjana Bilich et al. Science Translational Medicine
- Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines
- (2021) Emanuelle B. Gaspar et al. Human Vaccines & Immunotherapeutics
- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
- (2020) Jin-jin Zhang et al. ALLERGY
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19
- (2020) Ahmet Kursat Azkur et al. ALLERGY
- COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil
- (2020) Rodolfo Castro et al. Brazilian Journal of Infectious Diseases
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics
- (2020) Andrea Padoan et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
- (2020) Li Guo et al. CLINICAL INFECTIOUS DISEASES
- Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
- (2020) Juanjuan Zhao et al. CLINICAL INFECTIOUS DISEASES
- SARS-CoV-2 Vaccines: Status Report
- (2020) Fatima Amanat et al. IMMUNITY
- Clinical Testing For Covid-19
- (2020) Stephanie Ward et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection
- (2020) Paul Kellam et al. JOURNAL OF GENERAL VIROLOGY
- Performance of VivaDiag COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department
- (2020) Irene Cassaniti et al. JOURNAL OF MEDICAL VIROLOGY
- Virological assessment of hospitalized patients with COVID-2019
- (2020) Roman Wölfel et al. NATURE
- A serological assay to detect SARS-CoV-2 seroconversion in humans
- (2020) Fatima Amanat et al. NATURE MEDICINE
- The proximal origin of SARS-CoV-2
- (2020) Kristian G. Andersen et al. NATURE MEDICINE
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Coronavirus Disease 2019 (COVID-19) and healthcare-associated infections: Emerging and future challenges for public health in Brazil
- (2020) Rosineide Marques Ribas et al. Travel Medicine and Infectious Disease
- Humoral Immune Responses in COVID-19 Patients: A Window on the State of the Art
- (2020) Gabriel Siracusano et al. Frontiers in Immunology
- Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines
- (2020) Hsin-I Shih et al. Biomedical Journal
- Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking
- (2020) Ayse Basak Engin et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link?
- (2020) Candida J. Rebello et al. INTERNATIONAL JOURNAL OF OBESITY
- Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis
- (2020) Anaïs Scohy et al. JOURNAL OF CLINICAL VIROLOGY
- Qualitative assessment of SARS‐CoV‐2‐specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay
- (2020) Arantxa Valdivia et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
- (2020) Shibo Jiang et al. TRENDS IN IMMUNOLOGY
- SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays
- (2020) He S. Yang et al. CLINICA CHIMICA ACTA
- SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors
- (2020) Sarah E Benner et al. JOURNAL OF INFECTIOUS DISEASES
- Combination of serological total antibody and RT-PCR test for detection of SARS-COV-2 infections
- (2020) Pei Wang JOURNAL OF VIROLOGICAL METHODS
- SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
- (2020) Gregory A Poland et al. LANCET
- SARS-CoV-2 vaccines in development
- (2020) Florian Krammer NATURE
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays
- (2020) Oh Joo Kweon et al. PLoS One
- S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit
- (2020) Phuong Nguyen-Contant et al. mBio
- Blocking of the High-Affinity Interaction-Synapse Between SARS-CoV-2 Spike and Human ACE2 Proteins Likely Requires Multiple High-Affinity Antibodies: An Immune Perspective
- (2020) Indu Khatri et al. Frontiers in Immunology
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- Differences of SARS-CoV-2 serological test performance between hospitalized and outpatient COVID-19 cases
- (2020) Johannes Wolf et al. CLINICA CHIMICA ACTA
- Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples
- (2020) Livia Mazzini et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
- (2019) Carlota Dobaño et al. Nature Communications
- Maternal immunoglobulin G avidity as a diagnostic tool to identify pregnant women at risk of congenital cytomegalovirus infection
- (2017) Masatoki Kaneko et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Ageing and obesity similarly impair antibody responses
- (2016) D. Frasca et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Affinity Enhancement of Antibodies: How Low-Affinity Antibodies Produced Early in Immune Responses Are Followed by High-Affinity Antibodies Later and in Memory B-Cell Responses
- (2014) H. N. Eisen Cancer Immunology Research
- Correlation between Dengue-Specific Neutralizing Antibodies and Serum Avidity in Primary and Secondary Dengue Virus 3 Natural Infections in Humans
- (2013) Andreas Puschnik et al. PLoS Neglected Tropical Diseases
- Effects of age on H1N1-specific serum IgG1 and IgG3 levels evaluated during the 2011–2012 influenza vaccine season
- (2013) Daniela Frasca et al. Immunity & Ageing
- Analysis of IgG subclasses (IgG1 and IgG3) to recombinant SAG2A protein from Toxoplasma gondii in sequential serum samples from patients with toxoplasmosis
- (2012) Silas S. Santana et al. IMMUNOLOGY LETTERS
- Waning Antibody Levels and Avidity: Implications for MMR Vaccine-Induced Protection
- (2012) M. Kontio et al. JOURNAL OF INFECTIOUS DISEASES
- Antibodies with High Avidity to the gp120 Envelope Protein in Protection from Simian Immunodeficiency Virus SIVmac251Acquisition in an Immunization Regimen That Mimics the RV-144 Thai Trial
- (2012) Poonam Pegu et al. JOURNAL OF VIROLOGY
- Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
- (2008) Maria Florencia Delgado et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now